Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
M Golvit is a fixed-dose combination injectable multivitamin formulation developed by Gopal Lifesciences. It contains methylcobalamin (an active coenzyme form of vitamin B12), niacinamide (vitamin B3), and pyridoxine hydrochloride (vitamin B6). This combination is primarily indicated for the treatment of nutritional deficiencies, peripheral neuropathy, diabetic neuropathy, and related neurological disorders. Methylcobalamin supports nerve regeneration and myelin sheath repair, pyridoxine contributes to healthy nerve metabolism and neurotransmitter synthesis, and niacinamide supports cellular energy production and tissue metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methylcobalamin + niacinamide + pyridoxine.